PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Important Haplotype Information for SCN5A

Submitted by: Ping Yang and Andrew Wooldridge(PAT)
Reviewed by: Reviewed
Submitted date: Dec 21, 2006

There is One Important Haplotype for SCN5A.

  1. SCN5A: HapB
Gene HGNC Name: SCN5A
Haplotype Significance: This haplotype in the SCN5A promoter has been found only in Asian populations to date. It consists of 5 SNPs and an indel in tight linkage disequilibrium. The frequencies of the variant minor alleles were 0.24 and 0.21 in Japanese control and Japanese Brugada Syndrome (BS) populations, respectively. The polymorphisms were absent in Caucasian and African-American samples. It has been reported that this SCN5A promoter haplotype accounted for 25-45% of the variance in PR and QRS durations in the Japanese subjects studied, and also that it predicted extent of QRS interval prolongation on challenge with sodium channel blockers. It may therefore be a predictor of arrhythmia susceptibility (e.g. on drug exposure) in this population [PMID: 16415376].
Does this haplotype span more than one gene? No
Definitive Publication or Website: Bezzina CR, Shimizu W, Yang P, Koopmann TT, Tanck MW, Miyamoto Y, Kamakura S, Roden DM, Wilde AA. Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation. 2006;113:338-44 [PMID: 16415376].
Key PubMed IDs: 16415376
How many SNPs, indels, repeats define this haplotype? Six
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.